Abstract
Chrysin is one of flavones constituents of Orocylumineicum vent. It has been a hot spot as a potential chemopreventive agent and as a natural molecule with numerous biological activities such as antioxidant, antitumor, antiviral, anti-hypertension, anti-diabetic, antibacterial, and so on in recent years. Because of its poor solubility, small intestinal absorption, and the rapid metabolism of glycosylation, a large number of efforts had been made by domestic and foreign researchers on designing its analogs and conjugates to obtain compounds with improved efficacy and selectivity for developing more active drugs for clinic. This article reviews the current research of studying on chrysin derivatives including their properties and possible applications. Additionally, this article also presents the basic information concerning chemical reactivity of chrysin, relevant to the synthesis of its derivatives.
References
Bajgai SP, Prachyawarakorn V, Mahidol C, Ruchirawat S, Kittakoop P (2011) Hybrid flavan-chalcones, aromatase and lipoxygenase inhibitors, from Desmos cochinchinensis. Phytochemistry 72:2062–2067. doi:10.1016/j.phytochem.2011.07.002
Bojić M, Debeljak Z, Tomičić M, Medić-Šarić M, Tomić S (2011) Evaluation of antiaggregatory activity of flavonoid aglycone series. Nutr J. doi:10.1186/1475-2891-10-73
Brown E’, Hurd NS, McCall S, Ceremuga TE (2007) Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat. AANA J 75:333–337
Che H, Lim H, Kim HP, Park H (2011) A chrysin analog exhibited strong inhibitory activities against both PGE2 and NO production. Eur J Med Chem 46:4657–4660. doi:10.1016/j.ejmech.2011.04.044
Chen YH, Yang ZS, Wen CC, Chang YS, Wang BC, Hsiao CA, Shih TL (2012) Evaluation of the structure-activity relationship of flavonoids as antioxidants and toxicants of zebrafish larvae. Food Chem 134:717–724. doi:10.1016/j.foodchem.2012.02.166
Cho H, Yun CW, Park WK, Kong JY, Kim KS, Park Y, Lee S, Kim BK (2004) Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives. Pharmacol Res 49:37–43. doi:10.1016/S1043-6618(03)00248-2
Cushnie TP, Lamb AJ (2005) Antimicrobial activity of flavonoids. Int J Antimicrob Agents 26:343–356. doi:10.1016/j.ijantimicag.2005.09.002
Dao TT, Chi YS, Kim J, Kim HP, Kim S, Park H (2003a) Synthesis and PGE2 inhibitory activity of 5,7-dihydroxyflavones and their O-methylated flavone analogs. Arch Pharm Res 26:345–350. doi:10.1007/BF02976690
Dao TT, Oh JW, Chi YS, Kim HP, Sin KS, Park H (2003b) Synthesis and PGE2 inhibitory activity of vinylated and allylated chrysin analogues. Arch Pharm Res 26:581–584. doi:10.1007/BF02976703
Dao TT, Chi YS, Kim J, Kim HP, Kim S, Park H (2004a) Synthesis and inhibitory activity against COX-2 catalyzed prostaglandin production of chrysin derivatives. Bioorg Med Chem Lett 14:1165–1167. doi:10.1016/j.bmcl.2003.12.087
Dao TT, Kim SB, Sin KS, Kim S, Kim HP, Park H (2004b) Synthesis and biological activities of 8-arylflavones. Arch Pharm Res 27:278–282. doi:10.1007/BF02980059
De Souza Dos Santos MC, Gonçalves CF, Vaisman M, Ferreira AC, de Carvalho DP (2011) Impact of flavonoids on thyroid function. Food Chem Toxicol 49:2495–2502. doi:10.1016/j.fct.2011.06.074
Dhawan K, Kumar S, Sharma A (2002) Beneficial effects of chrysin and benzoflavone on virility in 2-year-old male rats. J Med Food 5:43–48
Fu B, Xue J, Li Z, Shi X, Jiang BH, Fang J (2007) Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis. Mol Cancer Ther 6:220–226. doi:10.1158/1535-7163.MCT-06-0526
Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, Nappo F, Lucarelli C, D’Onofrio F (1997) Vascular effects of acute hyperglycemia in humans are reversed by l-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 95:1783–1790. doi:10.1161/01.CIR.95.7.1783
Gresa-Arribas N, Serratosa J, Saura J, Solà C (2010) Inhibition of CCAAT/enhancer binding protein δ expression by chrysin in microglial cells results in anti-inflammatory and neuroprotective effects. J Neurochem 115:526–536. doi:10.1111/j.1471-4159.2010.06952.x
Harborne JB, Williams CA (2000) Advances in flavonoid research since 1992. Phytochemistry 55:481–504. doi:10.1016/S0031-9422(00)00235-1
Hu K, Wang W, Cheng H, Pan SS, Ren J (2011) Synthesis and cytotoxicity of novel chrysin derivatives. Med Chem Res 20:838–846. doi:10.1007/s00044-010-9395-1
Khoo BY, Chua SL, Balaram P (2010) Apoptotic effects of chrysin in human cancer cell lines. Int J Mol Sci 11:2188–2199. doi:10.3390/ijms11052188
Kim DC, Rho SH, Shin JC, Park HH, Kim D (2011) Inhibition of melanogenesis by 5,7-dihydroxyflavone (chrysin) via blocking adenylyl cyclase activity. Biochem Biophys Res Commun 411:121–125. doi:10.1016/j.bbrc.2011.06.108
Kröncke KD, Fehsel K, Suschek C, Kolb-Bachofen V (2001) Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int Immunopharmacol 1:1407–1420. doi:10.1016/S1567-5769(01)00087-X
Leonard E, Yan Y, Lim KH, Koffas MA (2005) Investigation of two distinct flavone synthases for plant-specific flavone biosynthesis in Saccharomyces cerevisiae. Appl Environ Microbiol 71:8241–8248. doi:10.1128/AEM.71.12.8241-8248.2005
Li HQ, Shi L, Li QS, Liu PG, Luo Y, Zhao J, Zhu HL (2009) Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics. Bioorg Med Chem 17:6264–6269. doi:10.1016/j.bmc.2009.07.046
Liang YC, Tsai SH, Tsai DC, Lin-Shiau SY, Lin JK (2001) Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages. FEBS Lett 496:12–18. doi:10.1016/S0014-5793(01)02393-6
Lim H, Jin JH, Park H, Kim HP (2011) New synthetic anti-inflammatory chrysin analog, 5,7-dihydroxy-8-(pyridine-4yl)flavone. Eur J Pharmacol 670:617–622. doi:10.1016/j.ejphar.2011.09.010
Lukačínová A, Mojžiš J, Beňačka R, Keller J, Maguth T, Kurila P, Vaško L, Rácz O, Ništiar F (2008) Preventive effects of flavonoids on alloxan-induced diabetes mellitus in rats. Acta Vet Brno 77:175–182. doi:10.2754/avb200877020175
Lv PC, Wang KR, Li QS, Chen J, Sun J, Zhu HL (2010) Design, synthesis and biological evaluation of chrysin long-chain derivatives as potential anticancer agents. Bioorg Med Chem 18:1117–1123. doi:10.1016/j.bmc.2009.12.048
Lv PC, Cai TT, Qian Y, Sun J, Zhu HL (2011) Synthesis, biological evaluation of chrysin derivatives as potential immunosuppressive agents. Eur J Med Chem 46:393–398. doi:10.1016/j.ejmech.2010.10.034
Martens S, Mithöfer A (2005) Flavones and flavone synthases. Phytochemistry 66:2399–2407. doi:10.1016/j.phytochem.2005.07.013
Mat Ali R, Houghton PJ, Raman A, Hoult JR (1998) Antimicrobial and antiinflammatory activities of extracts and constituents of Oroxylum indicum (L.) Vent. Phytomedicine 5:375–381. doi:10.1016/S0944-7113(98)80020-2
Mohammed HA, Ba LA, Burkholz T, Schumann E, Diesel B, Zapp J, Kiemer AK, Ries C, Hartmann RW, Hosny M, Jacob C (2011) Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors. Nat Prod Commun 6:31–34
Orhan DD, Ozçelik B, Ozgen S, Ergun F (2010) Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbiol Res 165:496–504. doi:10.1016/j.micres.2009.09.002
Peng SM, Zou XQ, HL D, Ding YL, Lin YB (2009) Synthesis and promotion angiogenesis effect of chrysin derivatives coupled to NO donors. Bioorg Med Chem Lett 19:1264–1266. doi:10.1016/j.bmcl.2008.12.116
Pick A, Müller H, Mayer R, Haenisch B, Pajeva IK, Weigt M, Bönisch H, Müller CE, Wiese M (2011) Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP). Bioorg Med Chem 19:2090–2102. doi:10.1016/j.bmc.2010.12.043
Pushpavalli G, Kalaiarasi P, Veeramani C, Pugalendi KV (2010) Effect of chrysin on hepatoprotective and antioxidant status in d-galactosamine-induced hepatitis in rats. Eur J Pharmacol 631:36–41. doi:10.1016/j.ejphar.2009.12.031
Puupponen-Pimiä R, Nohynek L, Meier C, Kähkönen M, Heinonen M, Hopia A, Oksman-Caldentey KM (2001) Antimicrobial properties of phenolic compounds from berries. J Appl Microbiol 90:494–507. doi:10.1046/j.1365-2672.2001.01271.x
Sawicka D, Car H, Borawska MH, Nikliński J (2012) The anticancer activity of propolis. Folia Histochem Cytobiol 50:25–37. doi:10.2478/18693
Scalbert A, Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130:2073S–2085S
Shin JS, Kim KS, Kim MB, Jeong JH, Kim BK (1999) Synthesis and hypoglycemic effect of chrysin derivatives. Bioorg Med Chem Lett 9:869–874. doi:10.1016/S0960-894X(99)00092-X
Shin EK, Kwon HS, Kim YH, Shin HK, Kim JK (2009) Chrysin, a natural flavone, improves murine inflammatory bowel diseases. Biochem Biophys Res Commun 381:502–507. doi:10.1016/j.bbrc.2009.02.071
Sun X, Huo X, Luo T, Li M, Yin Y, Jiang Y (2011) The anticancer flavonoid chrysin induces the unfolded protein response in hepatoma cells. J Cell Mol Med 15:2389–2398. doi:10.1111/j.1582-4934.2010.01244.x
Sun LP, Chen AL, Hung HC, Chien YH, Huang JS, Huang CY, Chen YW, Chen CN (2012) Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis. J Agric Food Chem 60:11748–11758. doi:10.1021/jf303261r
Suresh Babu K, Hari Babu T, Srinivas PV, Hara Kishore K, Murthy US, Rao JM (2006) Synthesis and biological evaluation of novel C(7) modified chrysin analogues as antibacterial agents. Bioorg Med Chem Lett 16:221–224. doi:10.1016/j.bmcl.2005.09.009
Suyenaga ES, Konrath EL, Dresch RR, Apel MA, Zuanazzi JA, Chaves CG, Henriques AT (2011) Appraisal of the antichemotactic activity of flavonoids on polymorphonuclear neutrophils. Planta Med 77:698–704. doi:10.1055/s-0030-1250516
Torres-Piedra M, Ortiz-Andrade R, Villalobos-Molina R, Singh N, Medina-Franco JL, Webster SP, Binnie M, Navarrete-Vázquez G, Estrada-Soto S (2010) A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition. Eur J Med Chem 45:2606–2612. doi:10.1016/j.ejmech.2010.02.049
Tsuji PA, Winn RN, Walle T (2006) Accumulation and metabolism of the anticancer flavonoid 5,7-dimethoxyflavone compared to its unmethylated analog chrysin in the Atlantic killifish. Chem Biol Interact 164:85–92. doi:10.1016/j.cbi.2006.08.023
Walle UK, Galijatovic A, Walle T (1999) Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. Biochem Pharmacol 58:431–438. doi:10.1016/S0006-2952(99)00133-1
Wang J, Qiu J, Dong J, Li H, Luo M, Dai X, Zhang Y, Leng B, Niu X, Zhao S, Deng X (2011) Chrysin protects mice from Staphylococcus aureus pneumonia. J Appl Microbiol 111:1551–1558. doi:10.1111/j.1365-2672.2011.05170.x
Wenzel U, Kuntz S, Brendel MD, Daniel H (2000) Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res 60:3823–3831
Woo KJ, Jeong YJ, Park JW, Kwon TK (2004) Chrysin-induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells. Biochem Biophys Res Commun 325:1215–1222. doi:10.1016/j.bbrc.2004.09.225
Zanoli P, Avallone R, Baraldi M (2000) Behavioral characterisation of the flavonoids apigenin and chrysin. Fitoterapia 71(1):S117–S123. doi:10.1016/S0367-326X(00)00186-6
Zhang S, Wang X, Sagawa K, Morris ME (2005) Flavonoids chrysin and benzoflavone, potent breast cancer resistance protein inhibitors, have no significant effect on topotecan pharmacokinetics in rats or mdr1a/1b (-/-) mice. Drug Metab Dispos 33:341–348. doi:10.1124/dmd.104.002501
Zheng X, Meng WD, Xu YY, Cao JG, Qing FL (2003) Synthesis and anticancer effect of chrysin derivatives. Bioorg Med Chem Lett 13:881–884. doi:10.1016/S0960-894X(02)01081-8
Zheng X, Zhao FF, Liu YM, Yao X, Zheng ZT, Luo X, Liao DF (2010) Synthesis and preliminary biological evaluation of chrysin derivatives as potential anticancer drugs. Med Chem 6:6–8. doi:10.2174/157340610791208763
Zou XQ, Peng SM, Hu CP, Tan LF, Yuan Q, Deng HW, Li YJ (2010) Synthesis, characterization and vasculoprotective effects of nitric oxide-donating derivatives of chrysin. Bioorg Med Chem 18:3020–3025. doi:10.1016/j.bmc.2010.03.056
Zou XQ, Peng SM, Hu CP, Tan LF, Deng HW, Li YJ (2011) Furoxan nitric oxide donor coupled chrysin derivatives: synthesis and vasculoprotection. Bioorg Med Chem Lett 21:1222–1226. doi:10.1016/j.bmcl.2010.12.077
Acknowledgments
We are grateful to the Construct Program of the Key Discipline in Hunan Province and University of South China Postgraduate Innovative Funds (2012XCX12) for financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, Y., Song, X., He, J. et al. Synthetic derivatives of chrysin and their biological activities. Med Chem Res 23, 555–563 (2014). https://doi.org/10.1007/s00044-013-0711-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-013-0711-4